Ameritas Investment Partners, Inc. Eq Rx, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.31 $8,497 - $11,824	5,119 Added 19.43%	31,468 $69,000
Q2 2023 Aug 11, 2023	BUY	$1.61 - $1.96 $17,045 - $20,750	10,587 Added 67.17%	26,349 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $5,176 - $32,986	5,507 Added 53.7%	15,762 $78,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.69 $32,816 - $58,350	10,255 New	10,255 $48,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.